{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:39:02Z","timestamp":1789519142702,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007684","name":"Asahi Glass Foundation","doi-asserted-by":"publisher","award":["nu"],"award-info":[{"award-number":["nu"]}],"id":[{"id":"10.13039\/100007684","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ratchada Funds","award":["RA60\/042"],"award-info":[{"award-number":["RA60\/042"]}]},{"name":"Ratchada Funds","award":["RA61\/050"],"award-info":[{"award-number":["RA61\/050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12035-020-02047-5","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:02:36Z","timestamp":1596585756000},"page":"4578-4597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunee","family":"Sirivichayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andressa Keiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Michelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"de Oliveira Seme\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor","family":"de Lima Pedr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania G.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decio S.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buranee","family":"Kanchanatawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"issue":"2","key":"2047_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","volume":"45","author":"RS Smith","year":"1995","unstructured":"Smith RS, Maes M (1995) The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 45(2):135\u2013141","journal-title":"Med Hypotheses"},{"issue":"1","key":"2047_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","volume":"66","author":"M Maes","year":"1997","unstructured":"Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharp\u00e9 S (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66(1):1\u201311","journal-title":"Psychiatry Res"},{"issue":"2","key":"2047_CR3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12035-019-01737-z","volume":"57","author":"C Roomruangwong","year":"2020","unstructured":"Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M (2020) The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Mol Neurobiol 57(2):778\u2013797","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2047_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/bmc-2019-0023","volume":"10","author":"M Maes","year":"2019","unstructured":"Maes M, Vojdani A, Geffard M, Moreira EG, Barbosa DS, Michelin AP, Seme\u00e3o LO, Sirivichayakul S et al (2019) Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways. Biomol Concepts 10(1):209\u2013225","journal-title":"Biomol Concepts"},{"key":"2047_CR5","first-page":"1","volume":"7","author":"M Maes","year":"2020","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Carvalho AF (2020) In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde. World J Biol Psychiatry 7:1\u201319","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"2047_CR6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12640-019-00112-z","volume":"37","author":"HK Al-Hakeim","year":"2020","unstructured":"Al-Hakeim HK, Almulla AF, Maes M (2020) The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study. Neurotox Res 37(3):753\u2013771","journal-title":"Neurotox Res"},{"issue":"2","key":"2047_CR7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s12035-017-0417-6","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Ormstad H, Anderson G, Maes M (2018) Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid. Mol Neurobiol 55(2):1524\u20131536","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2047_CR8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jep.12945","volume":"24","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sriswasdi S, Thika S, Stoyanov D, Sirivichayakul S, Carvalho AF, Geffard M, Maes M (2018) Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis. J Eval Clin Pract 24(4):879\u2013891","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"2047_CR9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12640-018-9937-8","volume":"35","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients. Neurotox Res 35(1):122\u2013138","journal-title":"Neurotox Res"},{"issue":"7","key":"2047_CR10","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1007\/s12035-018-1437-6","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Kanchanatawan B, Sirivichayakul S, Carvalho AF (2019) In schizophrenia, deficits in natural IgM isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome. Mol Neurobiol 56(7):5122\u20135135","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2047_CR11","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s12035-020-01882-w","volume":"57","author":"M Maes","year":"2020","unstructured":"Maes M, Sirivichayakul S, Matsumoto AK, Maes A, Michelin AP, de Oliveira SL, de Lima Pedr\u00e3o JV, Moreira EG et al (2020) Increased levels of plasma tumor necrosis factor-\u03b1 mediate schizophrenia symptom dimensions and neurocognitive impairments and are inversely associated with natural IgM directed to malondialdehyde and paraoxonase 1 activity. Mol Neurobiol 57(5):2333\u20132345","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2047_CR12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12640-019-00054-6","volume":"36","author":"M Maes","year":"2019","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019) Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia. Neurotox Res 36(2):306\u2013322","journal-title":"Neurotox Res"},{"issue":"3","key":"2047_CR13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12640-018-9987-y","volume":"35","author":"M Maes","year":"2019","unstructured":"Maes M, Kanchanatawan B, Sirivichayakul S, Carvalho AF (2019) In schizophrenia, increased plasma IgM\/IgA responses to gut commensal bacteria are associated with negative symptoms, neurocognitive impairments, and the deficit phenotype. Neurotox Res 35(3):684\u2013698","journal-title":"Neurotox Res"},{"key":"2047_CR14","doi-asserted-by":"crossref","first-page":"104408","DOI":"10.1016\/j.phrs.2019.104408","volume":"48","author":"G Morris","year":"2019","unstructured":"Morris G, Puri BK, Olive L, Carvalho AF, Berk M, Maes M (2019) Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses. Pharmacol Res 48:104408","journal-title":"Pharmacol Res"},{"issue":"3","key":"2047_CR15","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1007\/s12035-017-0465-y","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M (2018) Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation. Mol Neurobiol 55(3):2214\u20132226","journal-title":"Mol Neurobiol"},{"key":"2047_CR16","doi-asserted-by":"crossref","unstructured":"Matsumoto AK, Maes M, Supasitthumrong T, Maes A, Michelin AP, de Oliveira SL, de Lima Pedr\u00e3o JV, Moreira EG et al (2020) Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation. CNS Spectrums in press","DOI":"10.1017\/S1092852920001388"},{"key":"2047_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","volume":"45","author":"S Moylan","year":"2014","unstructured":"Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A, Hayley AC, Pasco JA et al (2014) Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45:46\u201362","journal-title":"Neurosci Biobehav Rev"},{"key":"2047_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpsychires.2015.07.003","volume":"68","author":"C Noto","year":"2015","unstructured":"Noto C, Ota VK, Gadelha A, Noto MN, Barbosa DS, Bonif\u00e1cio KL, Nunes SO, Cordeiro Q et al (2015) Oxidative stress in drug na\u00efve first episode psychosis and antioxidant effects of risperidone. J Psychiatr Res 68:210\u2013216","journal-title":"J Psychiatr Res"},{"issue":"11","key":"2047_CR19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/pcn.12333","volume":"69","author":"A Sarandol","year":"2015","unstructured":"Sarandol A, Sarandol E, Acikgoz HE, Eker SS, Akkaya C, Dirican M (2015) First-episode psychosis is associated with oxidative stress: effects of short-term antipsychotic treatment. Psychiatry Clin Neurosci 69(11):699\u2013707","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"2047_CR20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/schbul\/sbt001","volume":"40","author":"B Garc\u00eda-Bueno","year":"2014","unstructured":"Garc\u00eda-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Mart\u00ednez-Cengotitabengoa M, Pina-Camacho L, Rodr\u00edguez-Jim\u00e9nez R, S\u00e1iz PA et al (2014) Pro\u2212\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull 40(2):376\u2013387","journal-title":"Schizophr Bull"},{"issue":"6","key":"2047_CR21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jpsychires.2012.03.019","volume":"46","author":"M Pedrini","year":"2012","unstructured":"Pedrini M, Massuda R, Fries GR, de Bittencourt Pasquali MA, Schnorr CE, Moreira JC, Teixeira AL, Lobato MI et al (2012) Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res 46(6):819\u2013824","journal-title":"J Psychiatr Res"},{"key":"2047_CR22","doi-asserted-by":"crossref","first-page":"9616593","DOI":"10.1155\/2016\/9616593","volume":"2016","author":"K Kriisa","year":"2016","unstructured":"Kriisa K, Haring L, Vasar E, Koido K, Janno S, Vasar V, Zilmer K, Zilmer M (2016) Antipsychotic treatment reduces indices of oxidative stress in first-episode psychosis patients. Oxidative Med Cell Longev 2016:9616593","journal-title":"Oxidative Med Cell Longev"},{"key":"2047_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2017.03.038","volume":"253","author":"KM Boll","year":"2017","unstructured":"Boll KM, Noto C, Bonif\u00e1cio KL, Bortolasci CC, Gadelha A, Bressan RA, Barbosa DS, Maes M et al (2017) Oxidative and nitrosative stress biomarkers in chronic schizophrenia. Psychiatry Res 253:43\u201348","journal-title":"Psychiatry Res"},{"issue":"10","key":"2047_CR24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1177\/0269881119845820","volume":"33","author":"S Tsugawa","year":"2019","unstructured":"Tsugawa S, Noda Y, Tarumi R, Mimura Y, Yoshida K, Iwata Y, Elsalhy M, Kuromiya M et al (2019) Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: a systematic review and meta-analysis. J Psychopharmacol 33(10):1199\u20131214","journal-title":"J Psychopharmacol"},{"issue":"6","key":"2047_CR25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ijnp\/pyx015","volume":"20","author":"D Fraguas","year":"2017","unstructured":"Fraguas D, D\u00edaz-Caneja CM, Rodr\u00edguez-Quiroga A, Arango C (2017) Oxidative stress and inflammation in early onset first episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol 20(6):435\u2013444","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"2047_CR26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/schbul\/sby125","volume":"45","author":"D Fraguas","year":"2019","unstructured":"Fraguas D, D\u00edaz-Caneja CM, Ayora M, Hern\u00e1ndez-\u00c1lvarez F, Rodr\u00edguez-Quiroga A, Recio S, Leza JC, Arango C (2019) Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull 45(4):742\u2013751","journal-title":"Schizophr Bull"},{"key":"2047_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2018.08.006","volume":"91","author":"TK Das","year":"2019","unstructured":"Das TK, Javadzadeh A, Dey A, Sabesan P, Th\u00e9berge J, Radua J, Palaniyappan L (2019) Antioxidant defense in schizophrenia and bipolar disorder: a meta-analysis of MRS studies of anterior cingulate glutathione. Prog Neuro-Psychopharmacol Biol Psychiatry 91:94\u2013102","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"2047_CR28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","volume":"53","author":"M Zhang","year":"2010","unstructured":"Zhang M, Zhao Z, He L, Wan C (2010) A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci 53(1):112\u2013124","journal-title":"Sci China Life Sci"},{"issue":"2","key":"2047_CR29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.pnpbp.2006.09.012","volume":"31","author":"S Grignon","year":"2007","unstructured":"Grignon S, Chianetta JM (2007) Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations. Prog Neuro-Psychopharmacol Biol Psychiatry 31(2):365\u2013369","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2047_CR30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","volume":"30","author":"B Kirkpatrick","year":"1989","unstructured":"Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119\u2013123","journal-title":"Psychiatry Res"},{"key":"2047_CR31","unstructured":"Kittirathanapaiboon P, Khamwongpin M (2005) The validity of the mini international neuropsychiatric interview (M.I.N.I.) Thai version: Suanprung hospital, Department of Mental Health."},{"key":"2047_CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"2047_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","volume":"7","author":"NC Andreasen","year":"1989","unstructured":"Andreasen NC (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 7:49\u201358","journal-title":"Br J Psychiatry Suppl"},{"key":"2047_CR34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799\u2013812","journal-title":"Psychol Rep"},{"key":"2047_CR35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2047_CR36","doi-asserted-by":"crossref","unstructured":"Almulla AF, Al-Hakeim H, Maes M (2020) Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia. CNS Spectrums, in press:1\u201310","DOI":"10.31124\/advance.8304815.v1"},{"key":"2047_CR37","unstructured":"CERAD (1986) CERAD \u2013 an overview: the consortium to establish a registry for Alzheimer\u2019s disease; http:\/\/cerad.mc.duke.edu\/"},{"key":"2047_CR38","unstructured":"CANTAB (2018) The most validated cognitive research software.http:\/\/www.cambridgecognition.com\/cantab\/ October 1, 2018"},{"key":"2047_CR39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cca.2012.01.038","volume":"413","author":"M Hanasand","year":"2012","unstructured":"Hanasand M, Omdal R, Norheim KB, Gransson LG, Brede C, Jonsson G (2012) Improved detection of advanced oxidation protein products in plasma. Clin Chim Acta 413:901\u2013906","journal-title":"Clin Chim Acta"},{"key":"2047_CR40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0891-5849(91)90002-K","volume":"10","author":"B Gonzalez Flecha","year":"1991","unstructured":"Gonzalez Flecha B, Llesuy S, Boveris A (1991) Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10:93\u2013100","journal-title":"Free Radic Biol Med"},{"key":"2047_CR41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-011-1693-x","volume":"133","author":"C Panis","year":"2012","unstructured":"Panis C, Herrera ACSA, Victorino VJ, Campos FC, Freitas LF, De Rossi T, Colado Simao AN, Cecchini AL et al (2012) Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 133:89\u201397","journal-title":"Breast Cancer Res Treat"},{"key":"2047_CR42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/clinchem\/44.3.679","volume":"44","author":"JA Navarro-Gonzalvez","year":"1998","unstructured":"Navarro-Gonzalvez JA, Garcia-Benayas C, Arenas J (1998) Semiautomated measurement of nitrate in biological fluids. Clin Chem 44:679\u2013681","journal-title":"Clin Chem"},{"issue":"2","key":"2047_CR43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0009-8981(96)06394-2","volume":"255","author":"M Repetto","year":"1996","unstructured":"Repetto M, Reides C, Carretero MLG, Costa M, Griemberg G, Llesuy S (1996) Oxidative stress in blood of HIV infected patients. Clin Chim Acta 255(2):107\u2013117","journal-title":"Clin Chim Acta"},{"key":"2047_CR44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0076-6879(94)33044-1","volume":"233","author":"ML Hu","year":"1994","unstructured":"Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:380\u2013385","journal-title":"Methods Enzymol"},{"key":"2047_CR45","first-page":"275","volume":"35","author":"E Taylan","year":"2010","unstructured":"Taylan E, Resmi H (2010) The analytical performance of a microplatemethod for total sulfhydryl measurement in biological samples. Turkish J Biochem 35:275\u2013278","journal-title":"Turkish J Biochem"},{"key":"2047_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCGENETICS.108.811638","volume":"1","author":"RJ Richter","year":"2008","unstructured":"Richter RJ, Jarvik GP, Furlong CE (2008) Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ Cardiovasc Genet 1:147\u2013152","journal-title":"Circ Cardiovasc Genet"},{"key":"2047_CR47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistics Society Series b (Methodological) 57:289\u2013300","journal-title":"Journal of the Royal Statistics Society Series b (Methodological)"},{"key":"2047_CR48","doi-asserted-by":"crossref","unstructured":"Ringle CM, da Silva D, Bido D (2014) Structural equation modeling with the SmartPLS. Brazilian J Market- BJM Revista Brasileira de Marketing \u2013 ReMark Edi\u00e7\u00e3o Especial Vol 13, n. 2.","DOI":"10.5585\/remark.v13i2.2717"},{"key":"2047_CR49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pnpbp.2013.04.020","volume":"45","author":"Y Albayrak","year":"2013","unstructured":"Albayrak Y, \u00dcnsal C, Beyazy\u00fcz M, \u00dcnal A, Kulo\u011flu M (2013) Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. Prog Neuro-Psychopharmacol Biol Psychiatry 45:144\u2013149","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2047_CR50","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.12659\/MSM.894347","volume":"21","author":"Q Wu","year":"2015","unstructured":"Wu Q, Zhong ZM, Pan Y, Zeng JH, Zheng S, Zhu SY, Chen JT (2015) Advanced oxidation protein products as a novel marker of oxidative stress in postmenopausal osteoporosis. Med Sci Monit 21:2428\u20132432","journal-title":"Med Sci Monit"},{"issue":"2","key":"2047_CR51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cellsig.2006.06.013","volume":"19","author":"YW Yap","year":"2007","unstructured":"Yap YW, Whiteman M, Cheung NS (2007) Chlorinative stress: an under appreciated mediator of neurodegeneration? Cell Signal 19(2):219\u2013228","journal-title":"Cell Signal"},{"key":"2047_CR52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12979-017-0104-5","volume":"14","author":"M Casciaro","year":"2017","unstructured":"Casciaro M, Di Salvo E, Pace E, Ventura-Spagnolo E, Navarra M, Gangemi S (2017) Chlorinative stress in age-related diseases: a literature review. Immun Ageing 14:21","journal-title":"Immun Ageing"},{"issue":"2","key":"2047_CR53","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.sjbs.2018.08.024","volume":"26","author":"M Rasool","year":"2019","unstructured":"Rasool M, Malik A, Butt TT, Ashraf MAB, Rasool R, Zahid A, Waquar S, Asif M et al (2019) Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases. Saudi J Biol Sci 26(2):334\u2013339","journal-title":"Saudi J Biol Sci"},{"issue":"2","key":"2047_CR54","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/mmr.2016.6047","volume":"15","author":"C Yu","year":"2017","unstructured":"Yu C, Huang D, Wang K, Lin B, Liu Y, Liu S, Wu W, Zhang H (2017) Advanced oxidation protein products induce apoptosis, and upregulate sclerostin and RANKL expression, in osteocytic MLO-Y4 cells via JNK\/p38 MAPK activation. Mol Med Rep 15(2):543\u2013550","journal-title":"Mol Med Rep"},{"issue":"17","key":"2047_CR55","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1080\/10408398.2016.1165182","volume":"57","author":"M Est\u00e9vez","year":"2017","unstructured":"Est\u00e9vez M, Luna C (2017) Dietary protein oxidation: a silent threat to human health? Crit Rev Food Sci Nutr 57(17):3781\u20133793","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"6","key":"2047_CR56","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","volume":"97","author":"B Halliwell","year":"2006","unstructured":"Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97(6):1634\u20131658","journal-title":"J Neurochem"},{"key":"2047_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2016.09.004","volume":"10","author":"R Ding","year":"2016","unstructured":"Ding R, Jiang H, Sun B, Wu X, Li W, Zhu S, Liao C, Zhong Z et al (2016) Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia. Redox Biol 10:1\u201311","journal-title":"Redox Biol"},{"key":"2047_CR58","doi-asserted-by":"crossref","first-page":"116630","DOI":"10.1016\/j.jns.2019.116630","volume":"410","author":"WL de Carvalho Jennings Pereira","year":"2020","unstructured":"de Carvalho Jennings Pereira WL, Flauzino T, Alfieri DF, Oliveira SR, Kallaur AP, Sim\u00e3o ANC, Lozovoy MAB, Kaimen-Maciel DR et al (2020) Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: a follow-up study. J Neurol Sci 410:116630","journal-title":"J Neurol Sci"},{"issue":"1","key":"2047_CR59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12026-017-8960-9","volume":"66","author":"BM Scavuzzi","year":"2018","unstructured":"Scavuzzi BM, Sim\u00e3o ANC, Iriyoda TMV, Lozovoy MAB, Stadtlober NP, Franchi Santos LFDR, Flauzino T, de Medeiros FA et al (2018) Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift. Immunol Res 66(1):158\u2013171","journal-title":"Immunol Res"},{"issue":"1","key":"2047_CR60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146129","volume":"11","author":"MS Medeiros","year":"2016","unstructured":"Medeiros MS, Schumacher-Schuh A, Cardoso AM, Bochi GV, Baldissarelli J, Kegler A, Santana D, Chaves CM et al (2016) Iron and oxidative stress in Parkinson\u2019s disease: an observational study of injury biomarkers. PLoS One 11(1):e0146129","journal-title":"PLoS One"},{"key":"2047_CR61","doi-asserted-by":"publisher","unstructured":"Maes M, Supasitthumrong T, Limotai C, Michelin AP, Matsumoto AK, Seme\u00e3o LDO, Pedr\u00e3o JVDL, Moreira EG et al (2020) Increased oxidative stress toxicity and lowered antioxidant defenses in temporal lobe epilepsy and mesial temporal sclerosis: associations with psychiatric comorbidities. Preprints:2020010285. https:\/\/doi.org\/10.20944\/preprints202001.0285.v1","DOI":"10.20944\/preprints202001.0285.v1"},{"issue":"3","key":"2047_CR62","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12640-018-9906-2","volume":"34","author":"M Maes","year":"2018","unstructured":"Maes M, Bonifacio KL, Morelli NR, Vargas HO, Moreira EG, St Stoyanov D, Barbosa DS, Carvalho AF et al (2018) Generalized anxiety disorder (GAD) and comorbid major depression with GAD are characterized by enhanced nitro-oxidative stress, increased lipid peroxidation, and lowered lipid-associated antioxidant defenses. Neurotox Res 34(3):489\u2013510","journal-title":"Neurotox Res"},{"issue":"4","key":"2047_CR63","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1007\/s12035-017-0545-z","volume":"55","author":"C Gomes","year":"2018","unstructured":"Gomes C, Martinho FC, Barbosa DS, Antunes LS, P\u00f3voa HCC, Baltus THL, Morelli NR, Vargas HO et al (2018) Increased root canal endotoxin levels are associated with chronic apical periodontitis, increased oxidative and nitrosative stress, major depression, severity of depression, and a lowered quality of life. Mol Neurobiol 55(4):2814\u20132827","journal-title":"Mol Neurobiol"},{"key":"2047_CR64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2017.07.002","volume":"223","author":"C Roomruangwong","year":"2017","unstructured":"Roomruangwong C, Barbosa DS, Matsumoto AK, Nogueira AS, Kanchanatawan B, Sirivichayakul S, Carvalho AF, Duleu S et al (2017) Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby. J Affect Disord 223:49\u201358","journal-title":"J Affect Disord"},{"key":"2047_CR65","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bios.2017.08.001","volume":"99","author":"P Zhang","year":"2018","unstructured":"Zhang P, Wang H, Hong Y, Yu M, Zeng R, Long Y, Chen J (2018) Selective visualization of endogenous hypochlorous acid in zebrafish during lipopolysaccharide-induced acute liver injury using a polymer micelles-based ratiometric fluorescent probe. Biosens Bioelectron 99:318\u2013324","journal-title":"Biosens Bioelectron"},{"issue":"7","key":"2047_CR66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.it.2013.02.008","volume":"34","author":"CJ Thomas","year":"2013","unstructured":"Thomas CJ, Schroder K (2013) Pattern recognition receptor function in neutrophils. Trends Immunol 34(7):317\u2013328","journal-title":"Trends Immunol"},{"key":"2047_CR67","unstructured":"Oxford Biomedical Research (2010) Antioxidants and their measurement. Antioxidant assays: how do they compare, As accessed March 3, 2020 https:\/\/www.oxfordbiomed.com\/tech-resources\/oxidative-stress-best-practices\/antioxidants-and-their-measurement"},{"issue":"9","key":"2047_CR68","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0891-5849(00)00215-X","volume":"28","author":"I Rahman","year":"2000","unstructured":"Rahman I, MacNee W (2000) Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 28(9):1405\u20131420","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"2047_CR69","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bcp.2005.10.044","volume":"71","author":"S Biswas","year":"2006","unstructured":"Biswas S, Chida AS, Rahman I (2006) Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 71(5):551\u2013564","journal-title":"Biochem Pharmacol"},{"key":"2047_CR70","doi-asserted-by":"crossref","first-page":"104473","DOI":"10.1016\/j.psyneuen.2019.104473","volume":"111","author":"C Wei","year":"2020","unstructured":"Wei C, Sun Y, Chen N, Chen S, Xiu M, Zhang X (2020) Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia. Psychoneuroendocrinology 111:104473","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"2047_CR71","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12031-018-1165-4","volume":"66","author":"ZL Bai","year":"2018","unstructured":"Bai ZL, Li XS, Chen GY, Du Y, Wei ZX, Chen X, Zheng GE, Deng W et al (2018) Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia. J Mol Neurosci 66(3):428\u2013436","journal-title":"J Mol Neurosci"},{"issue":"11","key":"2047_CR72","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2174\/1570159X17666181227164947","volume":"7","author":"EG Moreira","year":"2019","unstructured":"Moreira EG, Boll KM, Correia DG, Soares JF, Rigobello C, Maes M (2019) Why should psychiatrists and neuroscientists worry about paraoxonase 1? Curr Neuropharmacol 7(11):1004\u20131020","journal-title":"Curr Neuropharmacol"},{"key":"2047_CR73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cca.2014.09.016","volume":"439","author":"A Gugliucci","year":"2015","unstructured":"Gugliucci A, Menini T (2015) Paraoxonase 1 and HDL maturation. Clin Chim Acta 439:5\u201313","journal-title":"Clin Chim Acta"},{"issue":"9","key":"2047_CR74","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","volume":"123","author":"Y Huang","year":"2013","unstructured":"Huang Y, Wu Z, Riwanto M, Gao S, Levison BS, Gu X, Fu X, Wagner MA et al (2013) Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 123(9):3815\u20133828","journal-title":"J Clin Invest"},{"key":"2047_CR75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-60761-350-3_14","volume":"660","author":"M Efrat","year":"2010","unstructured":"Efrat M, Aviram M (2010) Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids. Adv Exp Med Biol 660:153\u2013166","journal-title":"Adv Exp Med Biol"},{"issue":"1\u20133","key":"2047_CR76","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.schres.2015.06.009","volume":"166","author":"FF Brinholi","year":"2015","unstructured":"Brinholi FF, Noto C, Maes M, Bonif\u00e1cio KL, Brietzke E, Ota VK, Gadelha A, Cordeiro Q, Belangero SI, Bressan RA, Vargas HO, Higachi L, de FariasCC Moreira EG, Barbosa DS (2015) Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first episode psychosis. Schizophr Res 166(1\u20133):225\u2013230. https:\/\/doi.org\/10.1016\/j.schres.2015.06.009","journal-title":"Schizophr Res"},{"key":"2047_CR77","doi-asserted-by":"crossref","unstructured":"Meneses MJ, Silvestre R, Sousa-Lima I, Macedo MP (2019) Paraoxonase-1 as a regulator of glucose and lipid homeostasis: Impact on the onset and progression of metabolic disorders. Int J Mol Sci 20(16)","DOI":"10.3390\/ijms20164049"},{"key":"2047_CR78","first-page":"15","volume":"65","author":"M Petras","year":"2014","unstructured":"Petras M, Tatarkova Z, Kovalska M, Mokra D, Dobrota D, Lehotsky J, Drgova A (2014) Hyperhomocysteinemia as a risk factor for the neuronal system disorders. J Physiol Pharmacol 65:15\u201323","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"2047_CR79","first-page":"401","volume":"41","author":"G Orellana","year":"2013","unstructured":"Orellana G, Alvarado L, Mu\u00f1oz-Neira C, \u00c1vila R, M\u00e9ndez MF, Slachevsky A (2013) Psychosis-related matricide associated with a lesion of the ventromedial prefrontal cortex. J Am Acad Psychiatry Law 41(3):401\u2013406","journal-title":"J Am Acad Psychiatry Law"},{"key":"2047_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2013.00035","volume":"4","author":"G Orellana","year":"2013","unstructured":"Orellana G, Slachevsky A (2013) Executive functioning in schizophrenia. Front Psychiatry 4:1\u201315","journal-title":"Front Psychiatry"},{"issue":"9","key":"2047_CR81","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2174\/1568026620666200128143948","volume":"20","author":"HK Al-Hakeim","year":"2020","unstructured":"Al-Hakeim HK, Almulla AF, Al-Dujaili AH, Maes M (2020) Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia. Curr Top Med Chem 20(9):747\u2013758","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"2047_CR82","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s12640-019-00139-2","volume":"37","author":"D Stoyanov","year":"2020","unstructured":"Stoyanov D (2020) The reification of diagnosis in psychiatry. Neurotox Res 37(3):772\u2013774. https:\/\/doi.org\/10.1007\/s12640-019-00139-2","journal-title":"Neurotox Res"},{"key":"2047_CR83","unstructured":"RDoC initiative (2020) Research domain criteria (RDoC), https:\/\/www.nimh.nih.gov\/research\/research-funded-by-nimh\/rdoc\/index.shtml As assessed 19-7-2020"},{"key":"2047_CR84","first-page":"10:869","volume":"25","author":"D Stoyanov","year":"2019","unstructured":"Stoyanov D, Kandilarova S, Paunova R, Barranco Garcia J, Latypova A, Kherif F (2019) Cross-validation of functional MRI and paranoid-depressive scale: results from multivariate analysis. Front Psychiatry 25:10:869","journal-title":"Front Psychiatry"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02047-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02047-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02047-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T23:57:36Z","timestamp":1628121456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02047-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02047-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (No 298\/57), which is in compliance with the International Guideline for Human Research protection as required by the Declaration of Helsinki, The Belmont Report, CIOMS Guideline, and International Conference on Harmonization on Good Clinical Practice (ICH-GCP).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}]}}